MFDS — authorised 14 June 1965
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇰🇷 Maolate in South Korea
MFDS authorised Maolate on 14 June 1965
Marketing authorisation
Maolate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Maolate approved in South Korea?
Yes. MFDS authorised it on 14 June 1965.
Who is the marketing authorisation holder for Maolate in South Korea?
PHARMACIA AND UPJOHN holds the South Korean marketing authorisation.